C07D 209/16
Tryptamines
C07D209/16 (Tryptamines) appears on 534 US grants and 613 published applications in this corpus.
Search patents in C07D- Granted patents
- 534
- Published applications
- 613
- Assignees
- 322
- Inventors
- 1,557
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 10 | 0 |
| 1985 | 4 | 0 |
| 1986 | 5 | 0 |
| 1987 | 5 | 0 |
| 1988 | 7 | 0 |
| 1989 | 15 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 7 | 0 |
| 1994 | 8 | 0 |
| 1995 | 8 | 0 |
| 1996 | 13 | 0 |
| 1997 | 15 | 0 |
| 1998 | 11 | 0 |
| 1999 | 10 | 0 |
| 2000 | 9 | 0 |
| 2001 | 10 | 0 |
| 2002 | 12 | 13 |
| 2003 | 12 | 21 |
| 2004 | 12 | 24 |
| 2005 | 9 | 17 |
| 2006 | 15 | 30 |
| 2007 | 12 | 22 |
| 2008 | 11 | 16 |
| 2009 | 15 | 23 |
| 2010 | 15 | 17 |
| 2011 | 14 | 11 |
| 2012 | 8 | 9 |
| 2013 | 10 | 9 |
| 2014 | 10 | 9 |
| 2015 | 6 | 14 |
| 2016 | 10 | 13 |
| 2017 | 9 | 14 |
| 2018 | 10 | 7 |
| 2019 | 6 | 8 |
| 2020 | 5 | 6 |
| 2021 | 6 | 18 |
| 2022 | 15 | 34 |
| 2023 | 32 | 78 |
| 2024 | 53 | 78 |
| 2025 | 31 | 77 |
| 2026 | 24 | 45 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Crystalline forms of N,N-dimethyltryptamine and methods of using the same8 Sep 2026US 12,729,182 B2Atai Therapeutics, Inc.
- Compositions of matter and pharmaceutical compositions28 Jul 2026US 12,691,098 B2Atai Therapeutics, Inc.
- Tryptamine derivatives28 Jul 2026US 12,692,231 B2Caamtech, Inc.
- Compositions of matter and pharmaceutical compositions21 Jul 2026US 12,685,722 B2Atai Therapeutics, Inc.
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Recrystallisation of 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt)8 Oct 2026US 2026/0308121 A1Gh Research Ireland Limited
- Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine1 Oct 2026US 2026/0297028 A1Beckley Psytech Limited
- Alkoxy and carbamoyl quaternary amine salts as prodrugs of tryptamines1 Oct 2026US 2026/0297029 A1
- Synthesis of n,n-dimethyltryptamine-type compounds, methods, and uses10 Sep 2026US 2026/0265193 A1Cybin UK Ltd
Most cited
By later US patents
- Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them565US 5,514,718 AMerck Sharp & Dohme Corp. · 1996
- Deacetylase inhibitors168US 6,552,065 B2Novartis AG · 2003
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Modified carbocyanine dyes and their conjugates131US 6,977,305 B2Molecular Probes, Inc. · 2005
- Modified carbocyanine dyes and their conjugates105US 6,974,873 B2Molecular Probes, Inc. · 2005